FDA is expanding the Abbreviated 510(k) Program with a Safety and Performance-based Pathway for certain medical devices.
Read MoreZimmer Biomet, one of the leaders in the $50 billion global orthopedic medical device industry, is placing a big bet on this idea! They have just announced a large clinical trial to test their mymobilityTMapp working with the Apple Watch® to see if it can be a viable alternative to the current standard of care after hip and knee replacement surgery. They expect to enroll nearly 10,000 patients in this study over a period of two years.
Read More